Title |
Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative Colitis
|
---|---|
Published in |
Digestive Diseases and Sciences, August 2013
|
DOI | 10.1007/s10620-013-2828-1 |
Pubmed ID | |
Authors |
Sang Hyoung Park, Suk-Kyun Yang, Seung-Mo Hong, Soo-Kyung Park, Jong Wook Kim, Hyo Jeong Lee, Dong-Hoon Yang, Kee Wook Jung, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Jin-Ho Kim |
Abstract |
The role of infliximab in the treatment of patients with ulcerative colitis (UC) in Asia is still unclear. The aim of this study was to evaluate the clinical outcomes of infliximab therapy in Korean UC patients, including efficacy and predictors of response. |
Mendeley readers
The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 52 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 17% |
Student > Master | 8 | 15% |
Other | 4 | 8% |
Student > Ph. D. Student | 3 | 6% |
Professor | 3 | 6% |
Other | 13 | 25% |
Unknown | 12 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 54% |
Computer Science | 4 | 8% |
Nursing and Health Professions | 2 | 4% |
Agricultural and Biological Sciences | 1 | 2% |
Immunology and Microbiology | 1 | 2% |
Other | 3 | 6% |
Unknown | 13 | 25% |